Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

APOTEX-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack (184626)

ARTG ID

184626

ARTG Name

APOTEX-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

April 13, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Arrotex Pharmaceuticals Pty Ltd

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Active Ingredients

Ingredient Name

risedronate sodium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy